This decrease is certainly primarily linked to lower comparative income and benefit costs, lower legal expenditures and other cost-saving methods. Net loss was $5.9 million, or $0.09 per diluted and basic share, for the three-month period ended March 31, 2010, compared to $12.4 million, or $0.23 per basic and diluted share, for the same period in ’09 2009. This decrease is mainly related to lower comparative net R&D costs, lower SG&A expenditures and higher foreign exchange gains, partly offset simply by more affordable comparative license fee revenues and more affordable royalty and sales margins.According to the National Institute on SUBSTANCE ABUSE, 1 in 15 individuals who have a prescription painkiller for nonmedical reasons will attempt heroin next a decade. While Cunningham says the Albert Einstein College of Medicine includes a structured curriculum around how exactly to treat addiction, that isn’t the case at all medical institutions throughout the country. Cunningham says most doctors receive small education about addiction and are often badly equipped to take care of it. So, it’s no real surprise that doctors after that don’t treat addiction because they don’t really know how to perform it, they don’t really have the skills, they don’t really have the knowledge, plus they don’t have the confidence, she says. Cunningham and her co-workers note that multiple research have found discrimination on the part of doctors in prescribing and monitoring opioids.